TY - CHAP
T1 - Anxiety disorders
T2 - From bench to Bedside and Beyond
AU - Starke, Jonathan
AU - Fineberg, Naomi
AU - Stein, Dan
N1 - © Springer International Publishing AG, part of Springer Nature 2019. The final publication is available at Springer via https://doi.org/10.1007/978-3-319-70554-5_2
PY - 2018/7/7
Y1 - 2018/7/7
N2 - The anxiety disorders are prevalent, associated with high comorbidity and cause considerable disability. Despite efficacious treatment options, they are frequently misdiagnosed, and management is often suboptimal. With the recent publication of the DSM-5 and the imminent release of the ICD-11, there have been important debates about how best to categorize and conceptualize these disorders. In addition, their underlying neurobiology is being explored at multiple levels from systems neuroscience to molecular biology and genetics-an endeavour that is delivering insights with relevance to clinical practice. Furthermore, several international anxiety disorder treatment guidelines have recently been published, and large systematic reviews and meta-analyses have addressed important questions around clinical management. All of this indicates the need for an update on advances in this rapidly developing field, and this chapter therefore provides an overview of the epidemiology and classification, cognitive-affective neuroscience and clinical management of the anxiety disorders.
AB - The anxiety disorders are prevalent, associated with high comorbidity and cause considerable disability. Despite efficacious treatment options, they are frequently misdiagnosed, and management is often suboptimal. With the recent publication of the DSM-5 and the imminent release of the ICD-11, there have been important debates about how best to categorize and conceptualize these disorders. In addition, their underlying neurobiology is being explored at multiple levels from systems neuroscience to molecular biology and genetics-an endeavour that is delivering insights with relevance to clinical practice. Furthermore, several international anxiety disorder treatment guidelines have recently been published, and large systematic reviews and meta-analyses have addressed important questions around clinical management. All of this indicates the need for an update on advances in this rapidly developing field, and this chapter therefore provides an overview of the epidemiology and classification, cognitive-affective neuroscience and clinical management of the anxiety disorders.
UR - http://www.scopus.com/inward/record.url?scp=85063031699&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-70554-5_2
DO - 10.1007/978-3-319-70554-5_2
M3 - Chapter
AN - SCOPUS:85063031699
SN - 9783319705538
SP - 33
EP - 58
BT - Advances in Psychiatry
PB - Springer Nature Link
ER -